PCAT-1, a long noncoding RNA, regulates BRCA2 and controls homologous recombination in cancer

Cancer Research

Volumn 74, Issue 6, 2014, Pages 1651-1660

  Prensner, John R ^a,b   Chen, Wei ^c   Iyer, Matthew K ^a   Cao, Qi ^a,b   Ma, Teng ^d   Han, Sumin ^c   Sahu, Anirban ^a   Malik, Rohit ^a   Wilder Romans, Kari ^c   Navone, Nora ^h   Logothetis, Christopher J ^h   Araujo, John C ^h   Pisters, Louis L ^h   Tewari, Ashutosh K ⁱ   Canman, Christine E ^e   Knudsen, Karen E ^k   Kitabayashi, Naoki ^j   Rubin, Mark A ^j   Demichelis, Francesca ^a,l   Lawrence, Theodore S ^c   Chinnaiyan, Arul M ^a,b,c,f,g   Feng, Felix Y ^a,c,g   more..

^a UNIVERSITY OF MICHIGAN HEALTH SYSTEM   (United States)

^b Departments of Pathology   (United States)

^c UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^d Internal Medicine   (United States)

^e Departments of Pharmacology   (United States)

^f Departments of Urology   (United States)

^g Comprehensive Cancer Center ^*  (United States)

^h UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

ⁱ LeFrak Center for Robotic Surgery   (United States)

^j NEW YORK PRESBYTERIAN HOSPITAL   (United States)

^k THOMAS JEFFERSON UNIVERSITY   (United States)

^l UNIVERSITY OF TRENTO   (Italy)

more..

Author keywords

[No Author keywords available]

Indexed keywords

BRCA2 PROTEIN; LONG UNTRANSLATED RNA; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE 1; OLAPARIB; VELIPARIB;

3' UNTRANSLATED REGION; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CANCER INHIBITION; CELL DEATH; CONTROLLED STUDY; DNA REPAIR; DOUBLE STRANDED DNA BREAK; ENZYME INHIBITION; GENE; GENE EXPRESSION; GENE REPRESSION; GENETIC REGULATION; GENOTOXICITY; HOMOLOGOUS RECOMBINATION; HUMAN; HUMAN TISSUE; IN VIVO STUDY; MALE; MOUSE; NONHUMAN; PCAT 1 GENE; PRIORITY JOURNAL; PROSTATE CANCER; TUMOR SUPPRESSOR GENE;

3' UNTRANSLATED REGIONS; ANIMALS; ANTINEOPLASTIC AGENTS; BRCA2 PROTEIN; CELL DEATH; CELL LINE, TUMOR; DNA DAMAGE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MALE; MICE; MICE, SCID; PHTHALAZINES; PIPERAZINES; POLY(ADP-RIBOSE) POLYMERASES; PROSTATIC NEOPLASMS; RECOMBINATIONAL DNA REPAIR; RNA INTERFERENCE; RNA, LONG NONCODING; XENOGRAFT MODEL ANTITUMOR ASSAYS;

EID: 84896524997     PISSN: 00085472     EISSN: 15387445     Source Type: Journal    
DOI: 10.1158/0008-5472.CAN-13-3159     Document Type: Article

References (30)

1. Negrini S, Gorgoulis VG, Halazonetis TD. Genomic instability-An evolving hallmark of cancer. Nat Rev Mol Cell Biol 2010;11: 220-8.
2. Turner N, Tutt A, Ashworth A. Hallmarks of 'BRCAness' in sporadic cancers. Nat Rev Cancer 2004;4:814-9. (Pubitemid 39331153)
3. Turner NC, Reis-Filho JS, Russell AM, Springall RJ, Ryder K, Steele D, et al. BRCA1 dysfunction in sporadic basal-like breast cancer. Oncogene 2007;26:2126-32. (Pubitemid 46514749)
4. Jackson SP, Bartek J. The DNA-damage response in human biology and disease. Nature 2009;461:1071-8.
5. Roy R, Chun J, Powell SN. BRCA1 and BRCA2: different roles in a common pathway of genome protection. Nat Rev Cancer 2012;12: 68-78.
6. Farmer H, McCabe N, Lord CJ, Tutt AN, Johnson DA, Richardson TB, et al. Targeting the DNA repair defect in BRCA mutant cells as a therapeutic strategy. Nature 2005;434:917-21. (Pubitemid 40559006)
7. Bryant HE, Schultz N, Thomas HD, Parker KM, Flower D, Lopez E, et al. Specific killing of BRCA2-deficient tumours with inhibitors of poly(ADP-ribose) polymerase. Nature 2005;434: 913-7. (Pubitemid 40559005)
8. Fong PC, Boss DS, Yap TA, Tutt A, Wu P, Mergui-Roelvink M, et al. Inhibition of poly(ADP-ribose) polymerase in tumors from BRCA mutation carriers. N Engl J Med 2009;361:123-34.
9. Huarte M, Rinn JL. Large non-coding RNAs: missing links in cancer? Hum Mol Genet 2010;19:R152-61.
10. Prensner JR, Iyer MK, Balbin OA, Dhanasekaran SM, Cao Q, Brenner JC, et al. Transcriptome sequencing across a prostate cancer cohort identifies PCAT-1, an unannotated lincRNA implicated in disease progression. Nat Biotechnol 2011;29:742-9.
11. Gupta RA, Shah N, WangKC, Kim J, Horlings HM, Wong DJ, et al. Long non-coding RNA HOTAIR reprograms chromatin state to promote cancer metastasis. Nature 2010;464:1071-6.
12. Prensner JR, Chinnaiyan AM. The emergence of lncRNAs in cancer biology. Cancer Discov 2011;1:391-407.
13. Rinn JL, Kertesz M, Wang JK, Squazzo SL, Xu X, Brugmann SA, et al. Functional demarcation of active and silent chromatin domains in human HOX loci by noncoding RNAs. Cell 2007;129: 1311-23. (Pubitemid 46962090)
14. Wan G, Hu X, Liu Y, Han C, Sood AK, Calin GA, et al. A novel noncoding RNA lncRNA-JADE connects DNA damage signalling to histone H4 acetylation. EMBO J 2013;32:2833-47.
15. Wan G, Mathur R, Hu X, Liu Y, Zhang X, Peng G, et al. Long non-coding RNA ANRIL (CDKN2B-AS) is induced by the ATM-E2F1 signaling pathway. Cell Signal 2013;25:1086-95.
16. Adamson B, Smogorzewska A, Sigoillot FD, King RW, Elledge SJ. A genome-wide homologous recombination screen identifies the RNAbinding protein RBMX as a component of the DNA-damage response. Nat Cell Biol 2012;14:318-28.
17. Weinstock DM, Nakanishi K, Helgadottir HR, Jasin M. Assaying double-strand break repair pathway choice in mammalian cells using a targeted endonuclease or the RAG recombinase. Methods Enzymol 2006;409:524-40.
18. Baumann P, Benson FE, West SC. Human Rad51 protein promotes ATP-dependent homologous pairing and strand transfer reactions in vitro. Cell 1996;87:757-66. (Pubitemid 26386948)
19. Wahlberg E, Karlberg T, Kouznetsova E, Markova N, Macchiarulo A, Thorsell AG, et al. Family-wide chemical profiling and structural analysis of PARP and tankyrase inhibitors. Nat Biotechnol 2012; 30:283-8.
20. Wang KC, Yang YW, Liu B, Sanyal A, Corces-Zimmerman R, Chen Y, et al. A long noncoding RNA maintains active chromatin to coordinate homeotic gene expression. Nature 2011;472: 120-4.
21. Gong C, Maquat LE. lncRNAs transactivate STAU1-mediated mRNA decay by duplexing with 30 UTRs via Alu elements. Nature 2011;470: 284-8.
22. Bartel DP. MicroRNAs: target recognition and regulatory functions. Cell 2009;136:215-33.
23. Tsai MC, Manor O, Wan Y, Mosammaparast N, Wang JK, Lan F, et al. Long noncoding RNA as modular scaffold of histone modification complexes. Science 2010;329:689-93.
24. Prensner JR, IyerMK, Sahu A, Asangani IA, Cao Q, Patel L, et al. The long noncoding RNA SChLAP1 promotes aggressive prostate cancer and antagonizes the SWI/SNF complex. Nat Genet 2013;45: 1392-8.
25. Wang D, Garcia-Bassets I, Benner C, Li W, Su X, Zhou Y, et al. Reprogramming transcription by distinct classes of enhancers functionally defined by eRNA. Nature 2011;474:390-4.
26. Cesana M, Cacchiarelli D, Legnini I, Santini T, Sthandier O, Chinappi M, et al. A long noncoding RNA controls muscle differentiation by functioning as a competing endogenous RNA. Cell 2011;147: 358-69.
27. Salmena L, Poliseno L, Tay Y, Kats L, Pandolfi PP.A ceRNAhypothesis: the Rosetta Stone of a hidden RNA language? Cell 2011;146:353-8.
28. Francia S, Michelini F, Saxena A, Tang D, de Hoon M, Anelli V, et al. Site-specific DICER and DROSHA RNA products control the DNAdamage response. Nature 2012;488:231-5.
29. Konstantinopoulos PA, Spentzos D, Karlan BY, Taniguchi T, Fountzilas E, Francoeur N, et al. Gene expression profile of BRCAness that correlates with responsiveness to chemotherapy and with outcome in patients with epithelial ovarian cancer. J Clin Oncol 2010;28:3555-61.
30. Oonk AM, van Rijn C, SmitsMM,Mulder L, Laddach N, Savola SP, et al. Clinical correlates of 'BRCAness' in triple-negative breast cancer of patients receiving adjuvant chemotherapy. Ann Oncol 2012;23: 2301-5.